Currently held
- options_momentumlong1 contracts · CALL $70 exp Jul 30, 2026 · entry $3.72+$216.60 unrealized
COO
Cooper Companies IncHealth Careinsider_universeLast close $54.15Sep 13, 2026
Day +0.44%
Everything we've seen
- ·Sep 14, 3:32 PMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ?Sep 14, 3:20 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- !Sep 14, 3:20 PMsignalseverity 0.31
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- ?Sep 14, 3:20 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- !Sep 14, 3:20 PMsignalseverity 0.31
Agent 5 — Dip Buyer (Evolving) — dip_skipped
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- ·Sep 14, 3:17 PMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ·Sep 14, 3:02 PMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ·Sep 14, 2:47 PMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ·Sep 14, 2:32 PMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ·Sep 14, 2:32 PMstreamnews
The Cooper Companies (COO) Faces Near-Term Pressure from Slowing Contact Lens Demand
The Cooper Companies, Inc. (NASDAQ:COO) cut its fiscal 2026 profit and revenue forecasts after weaker-than-expected demand for contact lenses weighed on its CooperVision business. The company now expects adjusted earnings of $4.51–$4.55 per share, down from its previous forecast of $4.58–$4.66, while revenue guidance was reduced to $4.23–$4.25 billion from $4.29–$4.32 billion. Third-quarter revenue came in […]
- ·Sep 14, 2:32 PMstreamnews
3 of Wall Street’s Favorite Stocks We Approach with Caution
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
- ?Sep 14, 2:20 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- !Sep 14, 2:20 PMsignalseverity 0.31
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- ?Sep 14, 2:20 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- !Sep 14, 2:20 PMsignalseverity 0.31
Agent 5 — Dip Buyer (Evolving) — dip_skipped
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- ·Sep 14, 2:17 PMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ·Sep 14, 2:03 PMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ·Sep 14, 1:47 PMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ·Sep 14, 1:32 PMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ?Sep 14, 1:20 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- !Sep 14, 1:20 PMsignalseverity 0.31
Agent 5 — Dip Buyer (Evolving) — dip_skipped
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- ?Sep 14, 1:20 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- !Sep 14, 1:20 PMsignalseverity 0.31
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- ·Sep 14, 1:17 PMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ·Sep 14, 1:02 PMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ·Sep 14, 12:47 PMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ·Sep 14, 12:32 PMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ?Sep 14, 12:20 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- !Sep 14, 12:20 PMsignalseverity 0.31
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- ?Sep 14, 12:20 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- !Sep 14, 12:20 PMsignalseverity 0.31
Agent 5 — Dip Buyer (Evolving) — dip_skipped
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- ·Sep 14, 12:17 PMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ·Sep 14, 12:02 PMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ·Sep 14, 11:47 AMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ·Sep 14, 11:32 AMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ?Sep 14, 11:21 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- !Sep 14, 11:21 AMsignalseverity 0.31
Agent 5 — Dip Buyer (Evolving) — dip_skipped
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- ?Sep 14, 11:21 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- !Sep 14, 11:21 AMsignalseverity 0.31
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- ·Sep 14, 11:17 AMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ❖Sep 14, 11:07 AMnewsvia finnhub
3 of Wall Street’s Favorite Stocks We Approach with Caution
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
- ·Sep 14, 11:03 AMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ❖Sep 14, 10:55 AMnewsvia finnhub
The Cooper Companies (COO) Faces Near-Term Pressure from Slowing Contact Lens Demand
The Cooper Companies, Inc. (NASDAQ:COO) cut its fiscal 2026 profit and revenue forecasts after weaker-than-expected demand for contact lenses weighed on its CooperVision business. The company now expects adjusted earnings of $4.51–$4.55 per share, down from its previous forecast of $4.58–$4.66, while revenue guidance was reduced to $4.23–$4.25 billion from $4.29–$4.32 billion. Third-quarter revenue came in […]
- ·Sep 14, 10:47 AMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ·Sep 14, 10:32 AMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ·Sep 14, 10:32 AMstreamnews
International Markets and The Cooper Companies (COO): A Deep Dive for Investors
Examine The Cooper Companies' (COO) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
- ?Sep 14, 10:21 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- !Sep 14, 10:21 AMsignalseverity 0.31
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- ?Sep 14, 10:21 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- !Sep 14, 10:21 AMsignalseverity 0.31
Agent 5 — Dip Buyer (Evolving) — dip_skipped
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- ·Sep 14, 10:17 AMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ?Sep 14, 10:10 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
COO is up 1.84% today with no attributable headline, suggesting the move is driven by quiet institutional flow rather than a news catalyst. At 1.84%, the move is meaningful but not extreme — not yet in the zone where mean-reversion pressure becomes dominant. With 335 minutes remaining (essentially a full trading day still ahead), there is ample time for continuation to develop. The macro backdrop is mildly cautious: the T10Y2Y at 0.33 (1.9σ below trend) signals a flattening curve environment that tends to pressure financials and benefit defensives. COO (Cooper Companies, medical devices/contacts) is a defensive-leaning healthcare name, which is not negatively impacted by the curve context — if anything, the defensive tilt is a mild tailwind. No reversal signals are apparent from the data provided, and absence of news does not disqualify the move. Overall, this is a borderline momentum read with no strong reason to fade — assigning a modest continuation probability just above the trigger threshold.
- !Sep 14, 10:10 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
COO is up 1.84% today with no attributable headline, suggesting the move is driven by quiet institutional flow rather than a news catalyst. At 1.84%, the move is meaningful but not extreme — not yet in the zone where mean-reversion pressure becomes dominant. With 335 minutes remaining (essentially a full trading day still ahead), there is ample time for continuation to develop. The macro backdrop is mildly cautious: the T10Y2Y at 0.33 (1.9σ below trend) signals a flattening curve environment that tends to pressure financials and benefit defensives. COO (Cooper Companies, medical devices/contacts) is a defensive-leaning healthcare name, which is not negatively impacted by the curve context — if anything, the defensive tilt is a mild tailwind. No reversal signals are apparent from the data provided, and absence of news does not disqualify the move. Overall, this is a borderline momentum read with no strong reason to fade — assigning a modest continuation probability just above the trigger threshold.
- ·Sep 14, 10:03 AMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ·Sep 14, 9:47 AMstreamnews
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ❖Sep 14, 9:15 AMnewsvia finnhub
International Markets and The Cooper Companies (COO): A Deep Dive for Investors
Examine The Cooper Companies' (COO) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
- ?Sep 14, 7:01 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- !Sep 14, 7:01 AMsignalseverity 0.31
Agent 5 — Dip Buyer (Evolving) — dip_skipped
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- ?Sep 14, 7:00 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- !Sep 14, 7:00 AMsignalseverity 0.31
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- ❖Sep 12, 4:15 AMnewsvia finnhub
What Moved Markets This Week
Weekly stock market recap: Oracle earnings beat, CPI inflation and 10-year Treasury yield jump move stocks.
- ?Sep 11, 6:04 PMdecisionconsidered
Agent 4 — Dip Buyer (Frozen) — decide: skip
COO is down 31% from its 30-day high, which is a significant drawdown, but the news headlines don't indicate catastrophic deterioration — the weakness cited is in CooperVision, a known cyclical segment, while the company is actively pivoting toward fertility growth as an offset. However, the macro context is a headwind: the 5-year forward inflation rate is running 1.8σ above its 24-month trend, which pressures rate-sensitive and leveraged businesses like COO. The 10-Q and 8-K filings lack disclosed metrics, preventing confirmation of earnings quality, and the muted news sentiment suggests the market may be pricing in persistent segment weakness rather than a transitory dip.
- !Sep 11, 6:04 PMsignalseverity 0.31
Agent 4 — Dip Buyer (Frozen) — dip_skipped
COO is down 31% from its 30-day high, which is a significant drawdown, but the news headlines don't indicate catastrophic deterioration — the weakness cited is in CooperVision, a known cyclical segment, while the company is actively pivoting toward fertility growth as an offset. However, the macro context is a headwind: the 5-year forward inflation rate is running 1.8σ above its 24-month trend, which pressures rate-sensitive and leveraged businesses like COO. The 10-Q and 8-K filings lack disclosed metrics, preventing confirmation of earnings quality, and the muted news sentiment suggests the market may be pricing in persistent segment weakness rather than a transitory dip.
- ?Sep 11, 4:20 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- !Sep 11, 4:20 PMsignalseverity 0.31
Agent 5 — Dip Buyer (Evolving) — dip_skipped
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- ?Sep 11, 4:20 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- !Sep 11, 4:20 PMsignalseverity 0.31
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- ?Sep 11, 3:20 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- !Sep 11, 3:20 PMsignalseverity 0.32
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- ?Sep 11, 3:20 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- !Sep 11, 3:20 PMsignalseverity 0.32
Agent 5 — Dip Buyer (Evolving) — dip_skipped
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- ❖Sep 11, 2:42 PMnewsvia finnhub
Cooper Companies (COO) Bets on Fertility Growth Despite Weakness in CooperVision
The Cooper Companies Inc. (NASDAQ:COO), a leading medical device company, announced its third quarter fiscal 2026 results on September 9. Topline went up 1% to $1.066 billion in comparison with the same quarter last year, which also included 1% organic growth. The company posted quarterly adjusted diluted EPS of $1.15, which represented a 4% jump […]
- ?Sep 11, 2:21 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- !Sep 11, 2:21 PMsignalseverity 0.31
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- ?Sep 11, 2:21 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- !Sep 11, 2:21 PMsignalseverity 0.31
Agent 5 — Dip Buyer (Evolving) — dip_skipped
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- ?Sep 11, 1:20 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- !Sep 11, 1:20 PMsignalseverity 0.31
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- ?Sep 11, 1:20 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- !Sep 11, 1:20 PMsignalseverity 0.31
Agent 5 — Dip Buyer (Evolving) — dip_skipped
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- ?Sep 11, 12:21 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- !Sep 11, 12:21 PMsignalseverity 0.32
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- ?Sep 11, 12:20 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- !Sep 11, 12:20 PMsignalseverity 0.32
Agent 5 — Dip Buyer (Evolving) — dip_skipped
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- ❖Sep 11, 9:34 AMnewsvia finnhub
Mizuho Maintains Outperform on Cooper Companies, Lowers Price Target to $75
Mizuho analyst Anthony Petrone maintains Cooper Companies (NASDAQ:COO) with a Outperform and lowers the price target from $85 to $75.
- ❖Sep 11, 9:10 AMnewsvia finnhub
Deal Dispatch: Bending Spoons Acquires Miro For $1.35B, Kinetik Up For Sale, LIV Golf Bankruptcy
Read this week's top deal updates, including Bending Spoons' Miro deal, Chime's Stride Bank purchase, and the LIV Golf bankruptcy.
- ❖Sep 10, 11:49 PMnewsvia finnhub
Dow Tumbles Over 300 Points Amid Surge in Oil Prices: Fear & Greed Index Remains in ‘Fear’ Zone
U.S. stocks fell as oil topped $100 and inflation fears grew; CNN Fear & Greed dropped to 33, remaining in the Fear zone.
- ❖Sep 10, 9:53 PMnewsvia finnhub
COO Q2 Deep Dive: Inventory Actions and Strategic Review Shape Guidance
Medical device company CooperCompanies (NASDAQ:COO) missed Wall Street’s revenue expectations in Q2 CY2026, with sales flat year on year at $1.07 billion. The company’s full-year revenue guidance of $4.24 billion at the midpoint came in 1.5% below analysts’ estimates. Its non-GAAP profit of $1.15 per share was 2.7% above analysts’ consensus estimates.
- ❖Sep 10, 8:33 PMnewsvia finnhub
Why CooperCompanies (COO) Stock Is Trading Lower Today
Shares of medical device company CooperCompanies (NASDAQ:COO) fell 13.9% in the afternoon session after the company reported weak second-quarter results impacted by channel inventory destocking and decided to retain its CooperSurgical business.
- ?Sep 10, 4:26 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- !Sep 10, 4:26 PMsignalseverity 0.31
Agent 5 — Dip Buyer (Evolving) — dip_skipped
The drop is clearly idiosyncratic and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (BofA), received multiple analyst downgrades with commentary citing "limited near-term appeal," and is heading toward a 52-week low. Options flow is decisively bearish with put volume at a z-score of 72.82 versus call z-score of 4.30, a P/C ratio of 1.59 — signaling informed institutional hedging/selling, not dip-buying. There are no insider purchases to suggest internal conviction in a recovery.
- ?Sep 10, 4:26 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- !Sep 10, 4:26 PMsignalseverity 0.31
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
The 30.6% drop is confirmed as real and fundamental: COO missed Q3 revenue estimates due to destocking, failed to sell CooperSurgical at an attractive valuation (a strategic overhang), received multiple analyst downgrades, and is heading for a 52-week low with analysts citing "limited near-term appeal." The options flow is extremely bearish — put volume z-score of 72.82 is extraordinary, with a P/C ratio of 1.59, signaling strong directional bearishness rather than mere hedging. No insider buying has occurred post-drop, removing a key confirmation signal. The macro backdrop is hostile (10Y at 4.80%, elevated inflation expectations, broad market sell-off with oil spiking and yields at 19-year highs), and the healthcare sector is underperforming SPY on both 5-day and 30-day horizons.
- ❖Sep 10, 3:05 PMnewsvia finnhub
Thursday's session: top gainers and losers in the S&P500 index
Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.
- ❖Sep 10, 2:32 PMnewsvia finnhub
Why is CooperCompanies Stock Down 15% Today?
Cooper won't sell its Surgical arm, and it was forced to cut forward guidance. Wall Street didn't like that.
- ❖Sep 10, 2:24 PMnewsvia finnhub
Barron’s Got Cooper Wrong but the Contact-Lens Stock Now Looks Cheap
Cooper Cos. stock has fallen about 25% since Barron’s recommended it, but a low valuation, aggressive share buybacks, and takeover potential bolster the bull case.
- ❖Sep 10, 12:35 PMnewsvia finnhub
What's going on in today's session: S&P500 movers
Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.
- ❖Sep 10, 11:58 AMnewsvia finnhub
Cooper (COO) Q3 2026 Earnings Call Transcript
Record free cash flow and a $307M tax benefit offset near-term revenue headwinds.
- ❖Sep 10, 11:27 AMnewsvia finnhub
William Blair Downgrades Cooper Companies to Market Perform
William Blair analyst Steven Lichtman downgrades Cooper Companies (NASDAQ:COO) from Outperform to Market Perform.
- ❖Sep 10, 11:22 AMnewsvia finnhub
The Surprising Pockmarks On Cooper's Earnings That Caused Its Stock To Dive
Investors hammered Cooper Companies on Thursday after the medtech's fiscal third-quarter sales lagged Wall Street's expectations.
- ❖Sep 10, 11:13 AMnewsvia finnhub
Cooper Companies Failed to Sell CooperSurgical at Attractive Valuation, BofA Says
Cooper Companies (COO) could not sell CooperSurgical at an attractive valuation given competition fr
- ❖Sep 10, 10:47 AMnewsvia finnhub
2 Medical-Device Stocks Lighting Up the Options Pits
Both AXGN and COO are seeing unusual options volume
- ❖Sep 10, 10:45 AMnewsvia finnhub
COO Q3 Earnings Top Estimates, Revenues Miss on Destocking, Stock Down
Cooper Companies' Q3 EPS beats estimates as expense controls offset softer revenues, while U.S. inventory cuts pressure CooperVision and weigh on shares.
- ❖Sep 10, 10:35 AMnewsvia finnhub
Thursday's session: gap up and gap down stock in the S&P500 index
Curious about the S&P500 stocks that are gapping on Thursday? Explore the gap up and gap down stocks in the S&P500 index during today's session.
- ❖Sep 10, 10:26 AMnewsvia finnhub
Stock Market Today: Nasdaq 100 Tumbles as Oil Spikes 6%, Yields Hit 19-Year High
Crude jumped 6% and 30-year Treasury yields hit levels last seen in 2007 as a hot PPI print pushed Fed rate-hike odds toward 70% ahead of Friday's CPI.
- ❖Sep 10, 10:24 AMnewsvia finnhub
Wall Street Lunch: Yields Hit Financial Crisis Highs As Inflation Raises Fed Hike Odds
Our top story so far, treasury yields are on the march higher, hitting levels not seen since the Financial Crisis.
- ❖Sep 10, 10:19 AMnewsvia finnhub
Apple, TSMC, SpaceX, Cooper Cos., Macy’s, and More Stocks That Explain Today’s Market
Stocks fell on Thursday after wholesale inflation rose in line with expectations, increasing odds that the Federal Reserve will hike rates at its meeting next week. Taiwan Semiconductor Manufacturing Co. dropped 2.4% even as the Taiwanese chip manufacturer reported record monthly revenue for August.
- ❖Sep 10, 10:01 AMnewsvia finnhub
Wells Fargo Maintains Equal-Weight on Cooper Companies, Lowers Price Target to $61
Wells Fargo analyst Larry Biegelsen maintains Cooper Companies (NASDAQ:COO) with a Equal-Weight and lowers the price target from $66 to $61.
- ❖Sep 10, 9:52 AMnewsvia finnhub
Meta Platforms upgraded, Okta downgraded: Wall Street's top analyst calls
Meta Platforms upgraded, Okta downgraded: Wall Street's top analyst calls
- ❖Sep 10, 9:51 AMnewsvia finnhub
Stifel Maintains Buy on Cooper Companies, Lowers Price Target to $70
Stifel analyst Jonathan Block maintains Cooper Companies (NASDAQ:COO) with a Buy and lowers the price target from $85 to $70.
- ❖Sep 10, 9:07 AMnewsvia finnhub
Stocks making the biggest moves midday: Oracle, AeroVironment, American Eagle, Micron, Macy's & more
Here are some of the companies making headlines in midday trading.
- ❖Sep 10, 9:06 AMnewsvia finnhub
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 76.4% to $4.3 during Thursday's regular session. The market value of their outstanding shares is at $1.6 million. AEON Biopharma (AMEX:AEON) shares
- ❖Sep 10, 8:45 AMnewsvia finnhub
Why Cooper Stock Plunges After Earnings
Cooper Companies Stock falls after a revenue miss, weaker Q4 guidance and channel inventory pressure trigger analyst target cuts.
- ❖Sep 10, 8:37 AMnewsvia finnhub
Citigroup Maintains Neutral on Cooper Companies, Lowers Price Target to $60
Citigroup analyst Joanne Wuensch maintains Cooper Companies (NASDAQ:COO) with a Neutral and lowers the price target from $80 to $60.
- ❖Sep 10, 8:35 AMnewsvia finnhub
Which S&P500 stocks are moving before the opening bell on Thursday?
Discover the top S&P500 movers in Thursday's pre-market session and stay informed about market dynamics.
- ❖Sep 10, 8:33 AMnewsvia finnhub
Crude Oil Surges 6%; Macy’s Shares Fall After Q2 Results
U.S. stocks fell Thursday as the Dow dropped 300+ points; Macy’s slid on weak guidance, while oil rose and producer prices accelerated.
- ❖Sep 10, 8:30 AMnewsvia finnhub
These stocks that are showing activity before the opening bell on Thursday.
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
- ❖Sep 10, 8:30 AMnewsvia finnhub
The Cooper Companies, Inc. Q3 2026 Earnings Call Summary
Moby summary of The Cooper Companies, Inc.'s Q3 2026 earnings call
- ❖Sep 10, 8:09 AMnewsvia finnhub
Here Are Thursday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Amgen, AngloGold Ashanti, Caterpillar, Chewy, Meta Platforms, Novartis, NVIDIA, SK hynix, and More
Markets are taking a beating as crude oil surges past $100 and Treasury yields hit multi-year highs, setting up a make-or-break inflation report that could seal the Fed's next move. Wall Street analysts are already repositioning across semiconductors, biotech, and energy ahead of the fallout.
- ❖Sep 10, 7:39 AMnewsvia finnhub
Piper Sandler Downgrades Cooper Companies to Neutral, Lowers Price Target to $59
Piper Sandler analyst Jason Bednar downgrades Cooper Companies (NASDAQ:COO) from Overweight to Neutral and lowers the price target from $86 to $59.
- ❖Sep 10, 7:00 AMnewsvia finnhub
Cooper Stock Heads For 52-Week Low After Q3 Miss, Multiple Downgrades – Analyst Sees 'Limited Near-Term Appeal'
According to TheFly, Baird flagged the company’s increasingly challenging margin leverage heading into fiscal 2027, saying it limits COO stock's near-term appeal
- ❖Sep 10, 6:54 AMnewsvia finnhub
JP Morgan Maintains Neutral on Cooper Companies, Lowers Price Target to $58
JP Morgan analyst Robbie Marcus maintains Cooper Companies (NASDAQ:COO) with a Neutral and lowers the price target from $71 to $58.
- ❖Sep 10, 6:30 AMnewsvia finnhub
2 Reasons Cooper Companies Stock Is By Far the Worst in the S&P 500 Today
Contact lens maker Cooper Companies just sprung a surprise that no one saw coming. The market had been looking ahead to the potential sale of its women’s health and fertility business CooperSurgical. The stock tumbled more than 15% ahead of the open Thursday, by far the biggest faller in the in premarket trading.
- ❖Sep 10, 6:27 AMnewsvia finnhub
TSMC, Cooper Cos., American Eagle, Oracle, and More Stocks That Explain Today’s Market
FEATURE Stock futures were edging higher on Thursday, even as oil carried on rising having topped $100 a barrel for the first time since July the previous session. Taiwan Semiconductor Manufacturing Co.
- ❖Sep 10, 5:51 AMnewsvia finnhub
UBS Maintains Neutral on Cooper Companies, Lowers Price Target to $66
UBS analyst Patrick Wood maintains Cooper Companies (NASDAQ:COO) with a Neutral and lowers the price target from $75 to $66.
- ❖Sep 10, 5:45 AMnewsvia finnhub
Update: Cooper Shares Fall Pre-Bell After Fiscal Q3 Sales Miss Weighs on Adjusted Earnings Beat, Cut in Full-Year Guidance
(Updates with the stock move in the headline and the first paragraph.) Cooper Companies (COO) sha
- ❖Sep 10, 5:00 AMnewsvia finnhub
The Cooper Companies Inc (COO) (Q3 2026) Earnings Call Highlights: Record Cash Flow and a $307 ...
The Cooper Companies Inc (COO) beat earnings for the 11th straight quarter with record free cash flow of $273 million, but proactive U.S. channel destocking and a looming tax hike cloud fiscal 2027.
- ❖Sep 10, 4:50 AMnewsvia finnhub
Apple To $370? Here Are 10 Top Analyst Forecasts For Thursday
Analysts cut targets for AAPL, CHWY, COO, TYRA and CNM; raised DLR, DPZ, SIG, while ratings stayed unchanged.
- ❖Sep 10, 4:39 AMnewsvia finnhub
Stock Market Today: Dow Futures Rise, S&P 500 Falls as Trump Promises $5,000 Dividend After Midterm Elections— AVAV, AEO, COO, ORCL in Focus (UPDATED)
U.S. stock futures were mixed on Thursday, as the Dow Jones and S&P 500 indices advanced, while the Nasdaq 100 index fell.
- ❖Sep 10, 4:06 AMnewsvia finnhub
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 48.8% to $3.63 during Thursday's pre-market session. The market value of their outstanding shares is at $1.6 million. AEON Biopharma (AMEX:AEON) stock
- ❖Sep 10, 4:02 AMnewsvia finnhub
Limoneira Posts Downbeat Q3 Results, Joins Cooper Companies, Navan And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. futures rose, while Limoneira fell 8.4% after missing earnings and sales estimates. Resolution Minerals and Cooper led other premarket decliners.
- ❖Sep 10, 3:52 AMnewsvia finnhub
These Analysts Slash Their Forecasts On Cooper Companies Following Q3 Results
CooperCompanies beat Q3 EPS but missed sales and cut FY26 guidance; shares fell 16.8% as analysts lowered targets and downgraded the stock.
- ❖Sep 10, 3:38 AMnewsvia finnhub
Stocks making the biggest moves premarket: Macy's, Meta, Apple, Novartis and more
These are the stocks posting the largest moves in the premarket.
- ?Sep 9, 4:25 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
The dominant and overriding factor here is that earnings are IMMINENT — reporting today after market close — making this a pure binary event. The 18.6% drop from the 30-day high likely reflects pre-earnings anxiety and/or sector weakness (Health Care ranked 5th of 11, underperforming SPY on both 5d and 30d bases). Options flow shows a bearish skew with a P/C ratio of 1.31 and above-average put volume (z=+0.69), suggesting informed participants are hedging or positioning for downside. There are no insider cluster buys, no unusual call flow, and no SEC filings to provide a fundamental anchor or confirmation signal for a recovery thesis.
- !Sep 9, 4:25 PMsignalseverity 0.19
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
The dominant and overriding factor here is that earnings are IMMINENT — reporting today after market close — making this a pure binary event. The 18.6% drop from the 30-day high likely reflects pre-earnings anxiety and/or sector weakness (Health Care ranked 5th of 11, underperforming SPY on both 5d and 30d bases). Options flow shows a bearish skew with a P/C ratio of 1.31 and above-average put volume (z=+0.69), suggesting informed participants are hedging or positioning for downside. There are no insider cluster buys, no unusual call flow, and no SEC filings to provide a fundamental anchor or confirmation signal for a recovery thesis.
- ?Sep 9, 4:25 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip
The hard veto fires immediately: earnings are imminent today (0 days away, after market close), which creates a binary event risk that makes a 90-day rebound thesis structurally unsound. The three override conditions required — cluster insider buy, unusual call flow, and clearly strong fundamentals — are not all present simultaneously. There are no insider purchases in the last 30 days, options flow is modestly put-heavy (P/C ratio 1.31, put volume z=+0.69 vs. call volume z=-0.53), and no recent filings exist to confirm fundamental strength. Beyond the veto, the macro backdrop is a mild headwind with 10Y at 4.78% (above the 4.5% threshold) and the broader market under modest pressure today.
- !Sep 9, 4:25 PMsignalseverity 0.19
Agent 5 — Dip Buyer (Evolving) — dip_skipped
The hard veto fires immediately: earnings are imminent today (0 days away, after market close), which creates a binary event risk that makes a 90-day rebound thesis structurally unsound. The three override conditions required — cluster insider buy, unusual call flow, and clearly strong fundamentals — are not all present simultaneously. There are no insider purchases in the last 30 days, options flow is modestly put-heavy (P/C ratio 1.31, put volume z=+0.69 vs. call volume z=-0.53), and no recent filings exist to confirm fundamental strength. Beyond the veto, the macro backdrop is a mild headwind with 10Y at 4.78% (above the 4.5% threshold) and the broader market under modest pressure today.
- ?Sep 8, 4:22 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $16.33 cash available; close=$67.70.
- ?Sep 8, 4:22 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
COO (Cooper Companies) is down 10.6% from its 30-day high with no news headlines, SEC filings, or insider activity to explain the drop, suggesting this may be a macro/sector-driven pullback rather than a fundamental impairment. Health Care (XLV) ranks 2nd of 11 by 30-day relative strength with a positive 30-day outperformance vs. SPY (+2.75pts), but has shown recent 5-day weakness (-2.46pts), which may be dragging the stock lower alongside sector rotation pressure. Options flow is muted with below-average volumes on both calls and puts (both z-scores negative), offering no confirmation signal of informed buying or unusual directional conviction.
- ?Sep 8, 1:24 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $27.98 cash available; close=$68.27.
- ?Sep 8, 1:24 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
COO (Cooper Companies) is down 10.6% from its 30-day high with no news headlines, SEC filings, or insider activity to explain the drop, suggesting this may be a macro/sector-driven pullback rather than a fundamental impairment. Health Care (XLV) ranks 2nd of 11 by 30-day relative strength with a positive 30-day outperformance vs. SPY (+2.75pts), but has shown recent 5-day weakness (-2.46pts), which may be dragging the stock lower alongside sector rotation pressure. Options flow is muted with below-average volumes on both calls and puts (both z-scores negative), offering no confirmation signal of informed buying or unusual directional conviction.
- ?Sep 8, 12:01 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
COO is down 2.60% with no attributable headline, suggesting this is either sector rotation, quiet institutional selling, or sympathy with a broader market move. The macro context shows 5Y5Y inflation forward (T5YIFR) running 1.7σ above trend, which pressures rate-sensitive and growth-oriented names — COO (The Cooper Companies, medical devices/optics) can be rate-sensitive given its valuation profile. With 225 minutes remaining there is ample time for the move to extend, and intraday momentum of this magnitude without a news-driven catalyst can indicate systematic or quant selling that tends to persist into the close rather than reverse mid-session. No reversal signals are evident (no news-driven catalyst that could already be fading, no described rebound off lows). The absence of headlines removes a fade risk (i.e., no 'sell the news then recover' dynamic). The move is meaningful but not extreme, placing this in the ordinary momentum bucket. Slight lean toward continuation given time remaining and macro headwind, but conviction is modest without volume data or clear sector-wide confirmation.
- ?Sep 8, 11:25 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
COO (Cooper Companies) is down 10.6% from its 30-day high with no news headlines, SEC filings, or insider activity to explain the drop, suggesting this may be a macro/sector-driven pullback rather than a fundamental impairment. Health Care (XLV) ranks 2nd of 11 by 30-day relative strength with a positive 30-day outperformance vs. SPY (+2.75pts), but has shown recent 5-day weakness (-2.46pts), which may be dragging the stock lower alongside sector rotation pressure. Options flow is muted with below-average volumes on both calls and puts (both z-scores negative), offering no confirmation signal of informed buying or unusual directional conviction.
- ?Sep 8, 11:25 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $5.80 cash available; close=$67.83.
- ?Sep 8, 11:00 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
COO is down 2.74% with no headline catalyst, suggesting institutional flow or sector-driven selling rather than a news-driven spike that might revert quickly. The absence of news is not disqualifying — real size moved this. The macro context shows 5-year forward inflation expectations elevated at 1.7σ above trend, which pressures rate-sensitive and growth-oriented names broadly; COO (Cooper Companies, a medical device/contact lens company) carries some rate sensitivity in its valuation. However, with 285 minutes remaining there is ample time for either continuation or mean reversion, and without a clear catalyst or confirmation of volume strength, confidence is modest. The move is meaningful but not extreme enough to strongly signal capitulation or exhaustion. Slight lean toward continuation given the magnitude of the move and macro headwinds, but this is a borderline read.
- ?Sep 4, 7:23 PMdecisionconsidered
Agent 4 — Dip Buyer (Frozen) — decide: skip
The 10.9% drawdown from the 30-day high lacks any company-specific negative catalyst in the available evidence — no SEC filings flagging deterioration, no guidance cuts, and the news headlines reference unrelated healthcare companies (HealthEquity and Philips), suggesting the drop may be macro-driven or sector rotation. The elevated 5-year forward inflation rate (T5YIFR at 1.7σ above trend) is a headwind for rate-sensitive equities broadly, which could explain some valuation compression for COO as a medical device/healthcare company. Absent clear fundamental deterioration, the pullback has a reasonable mean-reversion case, though macro pressure moderates conviction.
- ?Sep 4, 4:24 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $67.76 cash available; close=$69.58.
- ?Sep 4, 4:23 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
COO (Cooper Companies) is down 10.6% from its 30-day high with no news headlines, SEC filings, or insider activity to explain the drop, suggesting this may be a macro/sector-driven pullback rather than a fundamental impairment. Health Care (XLV) ranks 2nd of 11 by 30-day relative strength with a positive 30-day outperformance vs. SPY (+2.75pts), but has shown recent 5-day weakness (-2.46pts), which may be dragging the stock lower alongside sector rotation pressure. Options flow is muted with below-average volumes on both calls and puts (both z-scores negative), offering no confirmation signal of informed buying or unusual directional conviction.
- ?Sep 4, 2:25 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $48.94 cash available; close=$69.77.
- ?Sep 4, 2:24 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
COO (Cooper Companies) is down 10.6% from its 30-day high with no news headlines, SEC filings, or insider activity to explain the drop, suggesting this may be a macro/sector-driven pullback rather than a fundamental impairment. Health Care (XLV) ranks 2nd of 11 by 30-day relative strength with a positive 30-day outperformance vs. SPY (+2.75pts), but has shown recent 5-day weakness (-2.46pts), which may be dragging the stock lower alongside sector rotation pressure. Options flow is muted with below-average volumes on both calls and puts (both z-scores negative), offering no confirmation signal of informed buying or unusual directional conviction.
- ?Sep 4, 1:25 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $43.21 cash available; close=$69.97.
- ?Sep 4, 1:24 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
COO (Cooper Companies) is down 10.6% from its 30-day high with no news headlines, SEC filings, or insider activity to explain the drop, suggesting this may be a macro/sector-driven pullback rather than a fundamental impairment. Health Care (XLV) ranks 2nd of 11 by 30-day relative strength with a positive 30-day outperformance vs. SPY (+2.75pts), but has shown recent 5-day weakness (-2.46pts), which may be dragging the stock lower alongside sector rotation pressure. Options flow is muted with below-average volumes on both calls and puts (both z-scores negative), offering no confirmation signal of informed buying or unusual directional conviction.
- ▣Sep 3, 8:00 PMjournaltime_stop
Agent 20 — SIR Price/Volume closed long 26 @ $70.64 (+$85.54)
Time stop: held 91 ≥ 90 days
- ?Sep 3, 1:23 PMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
COO (Cooper Companies) is down 10.6% from its 30-day high with no news headlines, SEC filings, or insider activity to explain the drop, suggesting this may be a macro/sector-driven pullback rather than a fundamental impairment. Health Care (XLV) ranks 2nd of 11 by 30-day relative strength with a positive 30-day outperformance vs. SPY (+2.75pts), but has shown recent 5-day weakness (-2.46pts), which may be dragging the stock lower alongside sector rotation pressure. Options flow is muted with below-average volumes on both calls and puts (both z-scores negative), offering no confirmation signal of informed buying or unusual directional conviction.
- ?Sep 3, 1:23 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $41.52 cash available; close=$70.03.
- ?Sep 3, 11:26 AMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $23.32 cash available; close=$69.65.
- ?Sep 3, 11:25 AMdecisionconsidered
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
COO (Cooper Companies) is down 10.6% from its 30-day high with no news headlines, SEC filings, or insider activity to explain the drop, suggesting this may be a macro/sector-driven pullback rather than a fundamental impairment. Health Care (XLV) ranks 2nd of 11 by 30-day relative strength with a positive 30-day outperformance vs. SPY (+2.75pts), but has shown recent 5-day weakness (-2.46pts), which may be dragging the stock lower alongside sector rotation pressure. Options flow is muted with below-average volumes on both calls and puts (both z-scores negative), offering no confirmation signal of informed buying or unusual directional conviction.
- ?Sep 2, 4:23 PMdecisionconsidered
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $26.70 cash available; close=$69.72.
- ▣Jun 16, 8:00 PMjournalstop
options_momentum closed long 100 @ $2.52 (-$72.78)
Stop: premium $2.52 ≤ trailing floor $2.77 (peak $3.69 × 0.75)
- ▣Jun 10, 8:00 PMjournalstop
options_momentum closed long 100 @ $2.87 (-$3.49)
Stop: premium $2.87 ≤ trailing floor $2.93 (peak $3.91 × 0.75)
- ▢Jun 10, 8:00 PMjournal
options_momentum opened long 100 @ $3.25
- ▢Jun 8, 8:00 PMjournal
Agent 7 — Day Trader opened long 44 @ $68.09
- ▣Jun 8, 8:00 PMjournaltime_stop
Agent 7 — Day Trader closed long 44 @ $68.64 (+$24.42)
EOD forced close — day trader never carries overnight
- ▢Jun 7, 8:00 PMjournal
options_momentum opened long 100 @ $2.91
- ▢Jun 4, 8:00 PMjournal
Agent 20 — SIR Price/Volume opened long 26 @ $67.35